ESSEX INVESTMENT MANAGEMENT CO LLC - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 49 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$654,130
-7.9%
105,335
-5.4%
0.11%
+8.1%
Q2 2023$710,349
+64.1%
111,340
+3.4%
0.10%
+57.1%
Q1 2023$432,773
+88947.9%
107,6550.0%0.06%
-17.1%
Q4 2022$486
-99.9%
107,655
-0.1%
0.08%
-41.1%
Q3 2022$808,000
-12.3%
107,711
-6.4%
0.13%
-13.4%
Q2 2022$921,000
-1.6%
115,0750.0%0.15%
+27.4%
Q1 2022$936,000
+5.2%
115,075
+8.1%
0.12%
+14.7%
Q4 2021$890,000
-2.6%
106,423
+18.9%
0.10%
-8.9%
Q3 2021$914,000
-2.5%
89,507
-1.8%
0.11%
+2.8%
Q2 2021$937,000
-8.1%
91,124
+1.0%
0.11%
-12.1%
Q1 2021$1,020,000
+4.7%
90,2320.0%0.12%
+2.5%
Q4 2020$974,000
-27.0%
90,232
-37.4%
0.12%
-36.6%
Q3 2020$1,334,000
-18.0%
144,188
-15.2%
0.19%
-28.5%
Q2 2020$1,626,000
+29.3%
170,0630.0%0.27%
+4.7%
Q1 2020$1,258,000
-13.2%
170,063
-2.3%
0.26%
+43.3%
Q4 2019$1,450,000
+85.7%
174,072
+25.9%
0.18%
+57.5%
Q3 2019$781,000
-27.8%
138,2320.0%0.11%
-23.6%
Q2 2019$1,082,000
+38.2%
138,232
+72.9%
0.15%
+27.6%
Q1 2019$783,000
-31.3%
79,972
-45.2%
0.12%
+30.3%
Q4 2018$1,140,000
-16.8%
145,850
+85.9%
0.09%
-44.7%
Q3 2018$1,370,000
+112.1%
78,439
-23.1%
0.16%
+98.8%
Q2 2018$646,000101,9620.08%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Battery Management Corp. 2,421,673$26,130,0006.61%
Roubaix Capital, LLC 206,502$2,228,0001.72%
Millrace Asset Group, Inc. 182,337$1,967,0001.37%
NEA Management Company, LLC 1,713,720$18,491,0000.49%
Zebra Capital Management LLC 32,084$346,0000.44%
Overbrook Management Corp 101,445$1,095,0000.27%
EAM Investors, LLC 99,763$1,076,0000.18%
Aristides Capital LLC 40,000$432,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,232$974,0000.12%
Cowen Prime Services LLC 13,500$146,0000.06%
View complete list of CHAMPIONS ONCOLOGY INC shareholders